Three-in-one molecule shows promise in helping certain breast cancer patients
(Medical College of Georgia at Augusta University) A newly designed three-part molecule could be the one answer patients with a certain form of breast cancer are looking for, scientists report.This chimera, created by a team at the Georgia Cancer Center, has the ability to simultaneously decrease the expression of three growth factors that are over-expressed in some cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

As Mammograms Became Widespread, Breast Tumor Size Shrank
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Breast Symptoms at Mammogram May Raise Future Cancer Risk
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

More Cases Are Reported of Unusual Cancer Linked to Breast Implants
Women with breast implants have an increased risk of a type of lymphoma that can usually be cured by surgery alone — but not always. (Source: NYT Health)
Source: NYT Health - March 21, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Implants Breasts Allergan Inc Breast Cancer Non-Hodgkin's Lymphoma Mentor Worldwide LLC Food and Drug Administration American Society for Aesthetic Plastic Surgery Source Type: news

Protecting Breast Cancer Patients From Cardiac Adverse Effects of Treatment With Anthracyclines and HER2-Targeted Therapies
During the 2018 Miami Breast Cancer Conference, cardiologist Dr. Jean-Bernard Durand discussed protecting patients who are being treated with anthracyclines and HER2-targeted therapies from serious cardiac adverse events. (Source: CancerNetwork)
Source: CancerNetwork - March 21, 2018 Category: Cancer & Oncology Authors: Jean-Bernard Durand, MD Tags: Conference Report Conferences/MBCC Source Type: news

Breast Symptoms at Mammogram May Raise Future Cancer Risk
WEDNESDAY, March 21, 2018 -- Women with breast symptoms at a regular cancer screening are more likely to develop breast cancer before their next screening, a new study finds. The study included women who took part in the Finnish National Breast... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2018 Category: General Medicine Source Type: news

Parasite Drug Shows Effectiveness Against Mesothelioma
Dr. Antonio Giordano believes his team has cleared the path to the next breakthrough in the treatment of malignant pleural mesothelioma. The advancement involves a new use for an old drug, pyrvinium pamoate, which doctors have successfully used for more than 50 years to treat infections of pinworm parasite. “This drug that no one expected to be involved with mesothelioma is potentially a new weapon against this aggressive type of tumor,” Giordano told Asbestos.com. “Our findings are exciting, very exciting. This one can move forward.” Giordano is the founder and director of the Sbarro Health Researc...
Source: Asbestos and Mesothelioma News - March 21, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Average size of breast tumors decreased following introduction of screening but is now increasing
(ECCO-the European CanCer Organisation) The average size of breast cancers at diagnosis decreased dramatically in the 1980s and 1990s following the introduction of screening, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2018 Category: Cancer & Oncology Source Type: news

Model created to help life insurers calculate breast cancer survivors' risk of death
(ECCO-the European CanCer Organisation) As early detection and treatment of breast cancer improves, more and more women are surviving the disease. However, they still face challenges, which include determining the moment when it might be reasonable to state they are 'cured' of the disease, and obtaining life insurance. At the European Breast Cancer Conference Dutch researchers describe how they have created a model to help life insurers calculate breast cancer survivors' risk of death more accurately (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Department of Defense grant to test promising treatment for triple-negative breast cancer
(University of Illinois at Chicago) A unique cell surface protein found on triple-negative type breast cancer cells called JAG1 is a promising new therapeutic target for this hard-to-treat and highly metastatic type of breast cancer, according to researchers at the University of Illinois at Chicago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2018 Category: Cancer & Oncology Source Type: news

Lymph node surgery could be avoided for some women with aggressive types of breast cancer
(ECCO-the European CanCer Organisation) Sentinel lymph node biopsies, where lymph nodes are surgically removed to check for signs of breast cancer spread, could be safely avoided for some women, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling
At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Patrick I. Borgen, MD Tags: Breast Cancer Conference Report Conferences/MBCC Source Type: news

Why Some Breast Cancer Becomes Resistant to Hormone Therapy Why Some Breast Cancer Becomes Resistant to Hormone Therapy
Acquired mutations in HER2 explain some of the resistance to hormone therapy seen in metastatic breast cancer; this unexpected finding offers a way to clinically manage these patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast cancer warning - five signs of deadly disease that could also affect men
BREAST cancer symptoms affect almost 60,000 people in the UK every year, including men, according to Cancer Research UK. These are the warning signs of a tumour, which indicate you should see your doctor - and breast pain isn ’t one of them. (Source: Daily Express - Health)
Source: Daily Express - Health - March 20, 2018 Category: Consumer Health News Source Type: news

Screening Mammography for Average-Risk Women Screening Mammography for Average-Risk Women
Learn about initiation, frequency, and duration of screening mammography for women at average risk of breast cancer.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Double mastectomy to prevent cancer reduces risk of dying in BRCA1 mutation carriers
(ECCO-the European CanCer Organisation) Healthy women who carry a breast cancer-causing mutation in the BRCA1 gene, not only reduce their risk of developing the disease but also their chances of dying from it if they have both breasts removed, according to new research presented at the 11th European Breast Cancer Conference. However, the study also found that for women with a mutation in the BRCA2 gene, there was no difference in their chances of dying from the disease whether they opted for double mastectomy or closer surveillance. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation
(ECCO-the European CanCer Organisation) The risk of a second breast cancer in patients with high-risk BRCA gene mutations can be more precisely predicted by testing for several other genetic variants, each of which are known to have a small impact on breast cancer risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+
(ECCO-the European CanCer Organisation) Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Cannabis oil: Meet the woman taking it for breast cancer recovery
Nikki Bednall says she takes cannabis oil through "desperation not recreation" after her breast cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 20, 2018 Category: Consumer Health News Source Type: news

Carboplatin in Neoadjuvant Chemo May Be Helpful in Triple-negative Breast Cancer Carboplatin in Neoadjuvant Chemo May Be Helpful in Triple-negative Breast Cancer
Carboplatin should be considered as a potential component of neoadjuvant chemotherapy for women with high-risk, triple-negative breast cancer, regardless of BRCA status, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

How California can break down barriers to breast cancer treatment
More than 29,000 women in California will be diagnosed with breast cancer in 2018. Many of them — especially low-income women, who suffer the worst survival rates — will face economic, emotional and structural obstacles to getting treatment and follow-up care.“Breast cancer is one of the most common diseases, so why is it still so hard for women to get adequate care?” asked Ninez Ponce, associate director of theUCLA Center for Health Policy Research and co-author of atwo-year study of breast cancer barriers in California.  “Women who face the hardship of illness should not also have ...
Source: UCLA Newsroom: Health Sciences - March 19, 2018 Category: Universities & Medical Training Source Type: news

Opinion: No, FDA Didnt Really Approve 23andMes BRCA Test
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers. (Source: The Scientist)
Source: The Scientist - March 19, 2018 Category: Science Tags: News & Opinion,Opinion Source Type: news

Medical News Today: Breast cancer: Obesity may hinder some treatments
Obesity, which is linked to lower survival in many cancers, may be why drugs that inhibit growth of blood vessels that feed cancer don't work, says study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 19, 2018 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Going beyond social support: fear of receiving compassion from others predicts depression symptoms in breast cancer patients - Trindade IA, Ferreira C, Borrego M, Ponte A, Carvalho C, Pinto-Gouveia J.
BACKGROUND: Recent studies have highlighted the importance of being able to receive compassion and affiliative signals from others. The main aim of the present study was to explore whether social support and fear of receiving compassion from others are pre... (Source: SafetyLit)
Source: SafetyLit - March 19, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

The use of immunotherapy to treat metastatic breast cancer
(Bentham Science Publishers) The Authors review immunotherapy attempts to treat metastatic breast cancer. They include a) the addition of cytokines to endocrine therapy, b) monoclonal antibodies associated to chemotherapy and c) vaccination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

Why are women at high breast cancer risk not having supplemental MRI screening?
(Mary Ann Liebert, Inc./Genetic Engineering News) Women at high lifetime breast cancer risk might benefit from breast MRI screening in addition to routine mammography, but a new study shows that breast MRI is greatly underutilized even though access is widely available. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

HRD-positive breast cancer patients fare better with adjuvant AC chemotherapy
(SWOG) People with tough-to-treat triple negative breast cancer, whose tumors also don't allow for double-strand DNA repair, fare better when treated with a common adjuvant breast cancer chemotherapy combination, according to results from a SWOG clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2018 Category: International Medicine & Public Health Source Type: news

In BRCA mutation carriers, obesity is linked with increased DNA damage
(The Endocrine Society) Being obese or having a higher body mass index (BMI) while carrying a BRCA (BReast CAncer gene) mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research suggests. The results of the study will be presented Sunday, March 18, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2018 Category: International Medicine & Public Health Source Type: news

TCM medicines confirmed to accelerate cell death of breast cancer tumors
(Natural News) A team of researchers from the Beijing University of Chinese Medicine has uncovered promising breast cancer treatment in two unlikely substances. One is tetrandrine, a natural plant-based alkaloid with health benefits ranging from pain alleviation to tumor growth inhibition, while the other is arsenic trioxide, a traditional Chinese remedy with a history of... (Source: NaturalNews.com)
Source: NaturalNews.com - March 17, 2018 Category: Consumer Health News Source Type: news

Abortions in the U.S. Are Safe and Effective, a New Report Says
The majority of legal abortions performed in the U.S. are safe, free of complications and devoid of long-term health effects, according to a comprehensive new report. A committee assembled by the National Academies of Sciences, Engineering, and Medicine analyzed available data on abortion safety, quality and care. The resulting report, published Friday, says the four major abortion methods used in the U.S. — medication, aspiration, induction and dilation and evacuation (D&E) — are all safe and effective, and that complications are rare. The vast majority of U.S. abortions — 90% — are also perfor...
Source: TIME: Health - March 16, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Reproductive Health Source Type: news

' You Don't Always Need to Do More': De-escalating Breast Cancer Therapy'You Don't Always Need to Do More': De-escalating Breast Cancer Therapy
Patients diagnosed with breast cancer could soon be benefiting from what could be described as the next step in personalized therapy: de-escalation of treatment to minimize adverse effects.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

Mayo Clinic's Clinical Trial Matching Project Sees Higher Enrollment in Breast Cancer Trials through Use of Artificial Intelligence
Mayo Clinic and IBM Watson Health (NYSE: IBM) have unveiled results from early use of the Watson for Clinical Trial Matching, an IBM cognitive computing system. Use of this system in the Mayo Clinic oncology practice has been associated with more patients enrolled in Mayo’s breast cancer clinical trials. (Source: eHealth News EU)
Source: eHealth News EU - March 16, 2018 Category: Information Technology Tags: Featured IBM Healthcare Business and Industry Source Type: news

Is artificial intelligence ethical in healthcare?
Artificial intelligence technology holds much promise for improving the quality...Read more on AuntMinnie.comRelated Reading: Deep learning may produce sharp reductions in DBT dose AI can help distinguish lung nodules on CT scans AI, radiomics help distinguish lung nodules on CT scans AI can spot large pneumothoraces on chest x-ray Artificial intelligence shows promise for breast cancer metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2018 Category: Radiology Source Type: news

Management of Early-Stage HER2-Positive Breast Cancer
During the 2018 Miami Breast Cancer Conference, Dr. Sara Hurvitz discussed current management options for patients with early-stage HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Sara Hurvitz, MD Tags: Conferences/MBCC News Source Type: news

Hidden Cancers Uncovered With Glowing Dyes
PHILADELPHIA (AP) — It was an ordinary surgery to remove a tumor — until doctors turned off the lights and the patient’s chest started to glow. A spot over his heart shined purplish pink. Another shimmered in a lung. They were hidden cancers revealed by fluorescent dye, an advance that soon may transform how hundreds of thousands of operations are done each year. Surgery has long been the best way to cure cancer. If the disease recurs, it’s usually because stray tumor cells were left behind or others lurked undetected. Yet there’s no good way for surgeons to tell what is cancer and what is not...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 15, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Cancer Dr. Mallika Marshall Local TV TumorGlow Source Type: news

Women in US Territories Get Lower Quality Breast Cancer Care Women in US Territories Get Lower Quality Breast Cancer Care
Older women with breast cancer who live in United States territories are less likely than their peers in the continental U.S. to receive recommended care, a study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Scientists Discover New Drugs To Treat Hot Flashes
BOSTON (CBS) — Scientists at Imperial College London have developed a new class of experimental drugs to treat menopausal hot flashes. In a clinical trial involving 37 women, the compound called MLE4901 reduced the number of hot flashes by almost three-quarters and significantly reduced the severity. The drug blocks a chemical in the brain called neurokinin B and in the study the drug also improved sleep and concentration during the 4-week study period. MLE4901 can affect liver function but two similar drugs which don’t have this side effect are being studied in larger patient trials including one in the U.S. t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 14, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Menopause Women's Health Source Type: news

Breast cancer patients in U.S. territories receive lower quality care
(Reuters Health) - Older women with breast cancer who live in United States territories are less likely than their peers in the continental U.S. to receive recommended care, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Too Few Early Breast CA Patients Given Formal Genetic Counseling
43.5 % of women with early - stage breast cancer with indications for risk evaluation get counseling (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 14, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news

Many Breast Cancer Patients Not Receiving Genetic Evaluation Many Breast Cancer Patients Not Receiving Genetic Evaluation
Many breast cancer patients who may benefit from a genetic evaluation are not receiving testing or counseling.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mammography finds more cancers in younger women
Compared with mammography screening in women 50 and older, adding screening...Read more on AuntMinnie.comRelated Reading: What are the risks of risk-based breast cancer screening? SABCS: Biannual breast MRI best for young women at high risk DBT in younger women mitigates mammography's 'harms' Groups hail study of breast screening in 40s 'Inexplicably,' doctors support breast screening at 40 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2018 Category: Radiology Source Type: news

Obesity may promote resistance to antiangiogenic therapy for breast cancer
(Massachusetts General Hospital) A research team led by Massachusetts General Hospital investigators has found, for the first time, that obesity and obesity-related molecular factors appear to induce resistance to antiangiogenic therapy in breast cancer patients and in mouse models of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 14, 2018 Category: Cancer & Oncology Source Type: news

EDC4: New gene involved in familial breast cancer
(Universitat Autonoma de Barcelona) An international research consortium led by Dr Jordi Surrall é s, director of the Genetics Service at the Hospital de Sant Pau and professor of Genetics at the UAB, and by Dr Miquel À ngel Pujana, director of the ProCURE Research Programme of the Catalan Institute of Oncology (ICO, IDIBELL), has identified a novel gene involved in this type of cancer, known as EDC4. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2018 Category: International Medicine & Public Health Source Type: news

Area surrounding a tumor impacts how breast cancer cells grow
(Oregon Health& Science University) A research team from Oregon Health& Science University, led by Joe Gray, Ph.D. and Jim Korkola, Ph.D. discover a tumor's 'microenvironment' plays a critical role in how HER2 positive breast cancer responds to treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2018 Category: International Medicine & Public Health Source Type: news

Ambry Genetics Launches AmbryScore to Assist Health Care Providers in...
New precision genetics risk tool helps clinicians better predict breast cancer risk(PRWeb March 14, 2018)Read the full story at http://www.prweb.com/releases/2018/03/prweb15315664.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 14, 2018 Category: Pharmaceuticals Source Type: news

Genetic Testing Underused in Breast Cancer Patients: Study
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 14, 2018 Category: Cancer & Oncology Source Type: news

Age-based Breast Cancer Screening Guidelines Ignore Race/Ethnicity Age-based Breast Cancer Screening Guidelines Ignore Race/Ethnicity
Age-based breast cancer screening guidelines that do not account for race may harm nonwhite populations, so lowering the screening age for these individuals should be considered, researchers in Boston say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 13, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Exploring Current Research on Immunotherapy for Breast Cancer
During the 2018 Miami Breast Cancer Conference, Dr. Elizabeth A. Mittendorf discussed immunotherapy concepts and strategies related to breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2018 Category: Cancer & Oncology Authors: Elizabeth A. Mittendorf, MD, PhD Tags: Breast Cancer Conferences/MBCC News Source Type: news

Lisinopril and Carvedilol Reduce Cardiotoxicity in HER2+ Breast Cancer
Lisinopril and carvedilol reduced cardiotoxicity in patients with HER2-positive breast cancer treated with trastuzumab and anthracyclines. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news

Optimal Duration of Endocrine Therapy for Breast Cancer Optimal Duration of Endocrine Therapy for Breast Cancer
According to a new study, five years of extended adjuvant letrozole for early breast cancer was not superior to 2.5 years.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news